These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 4040986

  • 1. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [Abstract] [Full Text] [Related]

  • 2. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K.
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A phase II study of NK171 (etoposide)].
    Kimura K, Niitani H.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
    Yoshida T, Nakanishi J, Ito K, Kobayashi S, Ohtake S, Nakamura S, Hattori K.
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
    [Abstract] [Full Text] [Related]

  • 7. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
    Kimura K, Yamada K, Yoshida T.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
    [Abstract] [Full Text] [Related]

  • 8. [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
    Furuse K.
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2352-7. PubMed ID: 3000299
    [Abstract] [Full Text] [Related]

  • 9. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
    Konno K, Nagahama F, Nakai Y, Nakabayashi T, Hiraga Y, Takebe K, Tamura M, Oizumi K, Sato M, Ito T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
    [Abstract] [Full Text] [Related]

  • 10. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y, Ohshima S, Kado M, Nakayama M, Shimokata K, Sakai S, Ito F, Chikata E, Hara K, Kanda T.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [Abstract] [Full Text] [Related]

  • 11. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group].
    Niijima T, Koyanagi T, Sakashita S, Origasa S, Akaza H, Machida T, Koiso K, Rinsho K, Aso Y, Suzuki K.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104
    [Abstract] [Full Text] [Related]

  • 12. [Effect of etoposide for pulmonary metastases from urogenital tract cancer].
    Fujita K, Murayama T, Sayama T.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2438-41. PubMed ID: 6497402
    [Abstract] [Full Text] [Related]

  • 13. [Phase II study of carboplatin in genitourinary cancer. Urological Cooperative Study Group on Carboplatin].
    Niijima T, Tazaki H.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2305-11. PubMed ID: 3044277
    [Abstract] [Full Text] [Related]

  • 14. [Phase I clinical study of NK 171 (etoposide)].
    Kimura K, Yamada K, Niitani H.
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):851-6. PubMed ID: 2985006
    [Abstract] [Full Text] [Related]

  • 15. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
    Noda K, Tanaka K, Ozaki M, Hirabayasi K, Hasegawa K, Nishiya I, Yakushiji M, Izumi R, Tomoda Y, Ogita Y, Sugimori H, Yamabe T, Kudo R, Yajima A, Terashima Y, Fujii S, Suzuoki Y, Okada H, Kono I, Ochiai K, Yamamoto T, Ikeda M, Umesaki N, Saito T, Niitani H.
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908
    [Abstract] [Full Text] [Related]

  • 16. [Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group].
    Ikeda M, Noda K, Hiura M, Tamaya T, Ozaki M, Hatae M, Ozawa M, Yamabe T, Tanaka K, Izumi R, Okada H, Ogita Y, Hoshiai H.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2249-57. PubMed ID: 9881082
    [Abstract] [Full Text] [Related]

  • 17. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Konishi I, Kitani T, Nagai K, Kanamaru A, Kohsaki M, Masaoka T, Shibata H, Horiuchi A, Tsubaki K, Kawagoe H.
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122
    [Abstract] [Full Text] [Related]

  • 18. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
    Saito T, Kasai Y, Wakui A, Furue H, Majima H, Nitani H, Niijima T, Takeda C, Abe O, Koyama Y.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850
    [Abstract] [Full Text] [Related]

  • 19. [Phase I study of an oral administration of VP 16-213].
    Ogawa M, Ota K, Oyama A, Fukuoka M, Takada M, Yoshida S, Sanpi K, Kimura I, Ohnoshi T, Kuraishi Y.
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2403-7. PubMed ID: 6639102
    [Abstract] [Full Text] [Related]

  • 20. [Effect of etoposide for urogenital tumors].
    Kinjo T, Murase T, Aota Y, Shimoji T, Mitsuya H.
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1267-71. PubMed ID: 4004290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.